Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

TaskUs Stock Drops Sharply as AI Outsourcing Play Gets Tested Again
·

TaskUs Stock Drops Sharply as AI Outsourcing Play Gets Tested Again

TaskUs shares slid over 6% on Wednesday, trailing the broader U.S. market. Investors marked down the outsourcing company again as it continued to tout artificial intelligence as its next growth driver. The stock changed hands at $6.06, off 41 cents from its prior close. Shares opened at $6.42 and moved between $6.06 and $6.54. Market cap sat near $564 million.
June 3, 2026
Frontdoor Shares Slip After Q1 Beat
·

Frontdoor Shares Slip After Q1 Beat

Frontdoor Inc stock edged down nearly 1% early Wednesday on Nasdaq. Shares opened at $61.55 and last traded at $61.31. The company, which sells home warranties, had a market cap near $4.43 billion. Frontdoor traded at about 17.5 times earnings, a price-to-earnings ratio that divides the share price by earnings per share. Stocks started out lower with a weaker tone on Wall Street. The S&P 500, Dow and Nasdaq all opened in the red as tensions in the Middle East gave oil another leg up and weighed on risk demand, Reuters reported.
June 3, 2026
Uni-Fuels Stock Drops Premarket as Shareholders Face a Big Vote Next Week
·

Uni-Fuels Stock Drops Premarket as Shareholders Face a Big Vote Next Week

Uni-Fuels Holdings Limited shares fell in U.S. premarket trading on Wednesday, putting fresh focus on a June 8 shareholder vote that could reshape the marine fuel supplier’s capital structure. The stock was last quoted at $0.66 before the bell, down 12%, with premarket volume of about 258,000 shares, Investing.com data showed. Premarket trading means deals made before the regular Nasdaq session opens. Why it matters now is simple: the vote comes while UFG trades below $1. The company is asking shareholders to let its board increase the votes attached to each Class B share from 10 to 100, increase authorised share capital, and carry out one or more share consolidations of up to 250-for-1 over two years. A share consolidation,
June 3, 2026
Mineralys Stock Drops Before Open After $150 Million Sale Tests Blood-Pressure Drug Bet
·

Mineralys Stock Drops Before Open After $150 Million Sale Tests Blood-Pressure Drug Bet

Mineralys Therapeutics shares fell before the bell on Wednesday after the company priced a $150 million common-stock offering at $26.50 a share to help fund a buyout of future royalties on its main hypertension drug. The stock was quoted at $26.35 at 9:00 a.m. EDT, down 8.7% from Tuesday’s Nasdaq close of $28.85; Mineralys said it would sell 5,660,378 shares, with the offering expected to close on or about June 4. The selloff matters because Mineralys is raising equity just as investors weigh how much control it can keep over lorundrostat, its lead pill for uncontrolled or resistant high blood pressure. An aldosterone synthase inhibitor — a drug designed to lower production of aldosterone, a hormone that can push blood
June 3, 2026
·

Verrica Shares Drop With Jefferies Conference Ahead, Cash Warning Still in Focus

Verrica Pharmaceuticals Inc. was last seen at $5.79 ahead of Wednesday’s U.S. open. Shares ended Tuesday at $5.80 on Nasdaq, off 2.2%. Traders are focused on YCANTH sales and the company’s cash runway as Verrica comes up on its June 4 investor presentation. U.S. cash markets were still closed. Nasdaq’s main trading session is 9:30 a.m. to 4:00 p.m. Eastern, with premarket trading open from 4:00 a.m. until the bell at 9:30 a.m., but volume tends to be lower in premarket. June 3 does not appear as a 2026 market holiday, according to Nasdaq.
June 3, 2026
Middlesex Water Stock Climbs Before the Open — The Quiet Utility Move Investors Are Watching
·

Middlesex Water Stock Climbs Before the Open — The Quiet Utility Move Investors Are Watching

Middlesex Water Co. shares were marked at $52.71 before Wednesday’s open, holding the prior session’s 1.8% rise as regulated water utilities drew buyers in a cautious U.S. tape. Premarket trading — the lighter session before regular 9:30 a.m. New York trading — was underway, Twelve Data showed. The move matters because it came without a fresh company announcement. Middlesex’s investor news page showed its latest release as the April 30 first-quarter report, after an April 24 dividend notice, putting the focus on price action, sector demand and the company’s recent operating update rather than a new corporate event.
June 3, 2026
WeRide Buyback and Madrid Robotaxi Deal Put Traders on Watch
····

WeRide Buyback and Madrid Robotaxi Deal Put Traders on Watch

WeRide Inc. faces Wall Street on Wednesday as investors look at its robotaxi launch in Europe and a recent buyback, while public market history for the company is still limited. The company’s Nasdaq-traded ADSs finished at $7.75 Tuesday, off 0.8% from Monday on roughly 2.5 million shares changing hands. The time is key since the main Nasdaq market hadn’t started trading yet in New York. Regular hours are 9:30 a.m. to 4:00 p.m. Eastern time. Traders can access pre-market from 4:00 a.m. June 3 doesn’t appear on Nasdaq’s list of 2026 market holidays.
June 3, 2026
Hemab Therapeutics Pulls Back After 53% IPO Surge
·

Hemab Therapeutics Pulls Back After 53% IPO Surge

Hemab Therapeutics Holdings is set to open Wednesday pre-market at $27.47, up around 53% from its $18 IPO price. Investors now turn to the company’s management, who are scheduled to present at the Jefferies Global Healthcare Conference on Thursday. Shares finished Tuesday up 1.25% after a volatile first month since going public, according to market data. Hemab is still a new Nasdaq biotech, so the focus has shifted away from the listing to whether it can keep its lead drug program on track for late-stage trials. The company is slated for a fireside chat at 9:20 a.m. ET on June 4 in New York at a healthcare conference that runs from June 2-4.
June 3, 2026
EOSE Stock Climbs Before Crucial Share Vote as Eos Energy Bulls Eye Grid-Storage Funding
····

EOSE Stock Climbs Before Crucial Share Vote as Eos Energy Bulls Eye Grid-Storage Funding

Eos Energy Enterprises shares rose on Tuesday, last quoted at $9.42, up 43 cents, or about 4.8%, after the zinc-battery storage company traded between $8.755 and $9.685 during the session. Volume reached about 26.4 million shares. The move came one day before Eos’ virtual annual meeting, set for Wednesday at 10 a.m. EDT, where investors will have a fresh chance to weigh the company’s financing path.
June 3, 2026
Aura Biosciences Stock Falls After Eye-Cancer Trial News
····

Aura Biosciences Stock Falls After Eye-Cancer Trial News

Aura Biosciences shares dropped roughly 4.2% to $6.89 late Tuesday, lagging a soft biotech sector. This came after Aura said on Monday that it hit a clinical-trial milestone. The SPDR S&P Biotech ETF slid about 4.2%. The iShares Nasdaq Biotechnology ETF lost around 2.9%. Aura said Monday it finished enrolling 108 patients in CoMpass, its Phase 3 study of bel-sar for early choroidal melanoma. Phase 3 trials are key late-stage tests before a drug approval. The first main results, or “topline” data, are due in the second half of 2027.
June 2, 2026
Funko Shares Fall as Attention Turns to $70 Million Turnaround Goal
····

Funko Shares Fall as Attention Turns to $70 Million Turnaround Goal

Funko Inc. dropped in Tuesday trading, down 2.3% at $5.46 on Nasdaq. The pullback came as investors looked for evidence that the collectibles maker’s recent bounce could last. Market cap for Funko was around $303 million. Why it’s in focus now: there’s no new company announcement behind the move. Funko’s latest post on its investor-relations page is still the May 7 Q1 earnings release, so the shares are moving with the tape, sentiment, and investors’ read on Funko’s profit turnaround, still in early days.
June 2, 2026
GIBO Stock Moves Before The Bell — The Tiny Volume Behind The AI Microcap’s Bounce
····

GIBO Stock Moves Before The Bell — The Tiny Volume Behind The AI Microcap’s Bounce

GIBO Holdings shares were indicated higher in thin premarket trading on Tuesday, clawing back part of Monday’s decline before the regular Nasdaq session opened. ADVFN showed the stock at $1.34 at 6:03 a.m. EDT, up 3.1% from a $1.30 close, on just 725 shares — volume, meaning the number of shares traded, too light to call a firm trend. That matters now because the move comes in the premarket session, the trading window before Nasdaq’s 9:30 a.m. open, when small stocks can move sharply on limited orders. Nasdaq lists regular trading from 9:30 a.m. to 4:00 p.m. Eastern time and its 2026 holiday calendar does not show a June 2 closure.
June 2, 2026
Masonglory Stock Gains, But $1 Nasdaq Listing Hurdle Still Ahead
····

Masonglory Stock Gains, But $1 Nasdaq Listing Hurdle Still Ahead

Masonglory Limited shares eased back in pre-market trading Tuesday, after the Hong Kong construction subcontractor surged Monday but stayed under the $1 mark it needs for Nasdaq compliance. The stock finished Monday at $0.5222, a 14.77% gain, then quoted at $0.5040 by 4:49 a.m. EDT in pre-market, a quieter period before the Nasdaq session. Masonglory faces a deadline now after saying in March that it got a Nasdaq notice. Its ordinary shares had closed under $1 for 30 consecutive business days from Jan. 28 to March 11. Nasdaq gave the company until Sept. 9, 2026, to fix the issue and meet compliance. The exchange requires listed shares to trade above $1 as part of its minimum bid price rule.
June 2, 2026
Abony Acquisition Shares Quiet as $230 Million SPAC Lingers
····

Abony Acquisition Shares Quiet as $230 Million SPAC Lingers

Abony Acquisition Corp. I Class A shares ended Monday at $9.89, trading just 6,449 shares. The Nasdaq-listed SPAC is still near its cash level. The company is a blank-check firm, set up to raise funds and then seek a merger with a private target. Why does this matter? Abony is still waiting. For investors, the main point now isn’t revenue or earnings—it’s the cash in trust as management keeps looking for a deal.
June 2, 2026
indie Semiconductor Stock Drops After Hours as Filings Raise New Questions for INDI Investors
····

indie Semiconductor Stock Drops After Hours as Filings Raise New Questions for INDI Investors

indie Semiconductor shares slipped in late Monday trading, lagging a firmer Nasdaq-linked tape, as investors weighed fresh compensation filings and an insider-sale report rather than a new operating update from the automotive-chip supplier. The stock was last at $4.87, down about 2.1%, after trading between $4.83 and $5.13 on volume of 4.45 million shares. The move matters now because the latest disclosures touch share count and insider selling, two pressure points for a small chip company still working toward steady profitability. For holders, the question is not just whether indie can sell more sensor chips into cars and industrial machines, but how much equity it may need to issue along the way.
June 2, 2026
Hydrofarm Clears $1; Traders Still Wary Over Debt Signal
····

Hydrofarm Clears $1; Traders Still Wary Over Debt Signal

Hydrofarm Holdings Group was last seen at $1.02 on Monday in late U.S. hours, trading lightly but sticking above $1 in a slow day for the Nasdaq hydroponics company. About 15,400 shares changed hands, under the latest average, with a range from 98 cents to $1.03. Hydrofarm is not your standard small-cap rebound story. The company is operating under a lender forbearance right now. That’s a temporary deal where lenders hold back on enforcing remedies after a debt default, as Hydrofarm looks to keep its liquidity together.
June 2, 2026
Aclaris Dips Ahead of Jefferies, With Focus on 2026 Trial Data
····

Aclaris Dips Ahead of Jefferies, With Focus on 2026 Trial Data

Aclaris Therapeutics dropped 12.5 cents to $4.43 late Monday, underperforming broad biotech indexes after little recent news from the drugmaker. The SPDR S&P Biotech ETF lost 1.9%. The iShares Nasdaq Biotechnology ETF slid 1.4%. An ETF is a basket of securities trading like a single stock. Aclaris’ next shot with investors is coming up. The Wayne, Pennsylvania company said CEO Dr. Neal Walker and other executives will take part in a fireside chat at the Jefferies Global Healthcare Conference in New York on Thursday at 2 p.m. ET. Its investor-relations site hasn’t posted anything newer than the May 28 release.
June 1, 2026
Cellectis Shares Dip Ahead of June Data Investors Wait For
····

Cellectis Shares Dip Ahead of June Data Investors Wait For

Cellectis S.A. ADRs slipped Monday, with the U.S.-listed gene-editing biotech trading near session lows. Shares last quoted at $3.44, down 8 cents, or 2.3%. Cellectis opened at $3.55, hit a high of $3.69, and traded only 37,375 shares in light action. Cellectis shares dropped in a slumping biotech sector, with no new disclosure from the company. The SPDR S&P Biotech ETF finished down roughly 1.7%. The iShares Nasdaq Biotechnology ETF slid 1.4%. Cellectis’ most recent update on its press page was a May 20 announcement about its June 25 annual meeting.
June 1, 2026
1 … 22 23 24 25 26 … 244